- Report
- April 2022
- 40 Pages
Japan
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
Russia
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
South Korea
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
United States
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2022
- 40 Pages
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2022
- 40 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2022
- 100 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- March 2022
- 100 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- January 2022
- 40 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- January 2022
- 40 Pages
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2020
- 40 Pages
South Korea
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2020
- 40 Pages
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Newsletter
- November 2024
- 8 Pages
China
From €3128EUR$3,149USD£2,601GBP
- Report
- February 2024
- 54 Pages
China
From €1788EUR$1,800USD£1,487GBP
- Report
- February 2024
- 107 Pages
China
From €1788EUR$1,800USD£1,487GBP
- Report
- August 2023
- 115 Pages
Global
From €3800EUR$3,825USD£3,159GBP
€4471EUR$4,500USD£3,717GBP
- Report
- March 2023
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- October 2022
- 25 Pages
Global
€12170EUR$12,250USD£10,118GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more